JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
Victory Capital Holdings
VCTR
$7B
| $4.7M | ﹤0.01% |
160,690
-29,220
| -15% | -$889K |
2020 Q1
12 quarters
|
|
2752
Brookfield Renewable
BEP
$8.83B
| $4.7M | ﹤0.01% |
149,050
+101,984
| +217% | +$2.88M |
2020 Q2
11 quarters
|
|
2753
Installed Building Products
IBP
$5.13B
| $4.69M | ﹤0.01% |
41,117
+12,350
| +43% | +$1.33M |
2017 Q1
24 quarters
|
|
2754
DoubleVerify
DV
$2.11B
| $4.69M | ﹤0.01% |
155,470
+118,285
| +318% | +$3.1M |
2021 Q2
7 quarters
|
|
|
NVO
2755
CALL
Novo Nordisk
NVO
$166B
| $4.68M | ﹤0.01% |
58,800
+53,800
| +1,076% | +$3.81M |
2022 Q4
1 quarter
|
|
2756
Under Armour Class C
UA
$2.03B
| $4.68M | ﹤0.01% |
548,149
+15,391
| +3% | +$142K |
2016 Q2
27 quarters
|
|
2757
Pilgrim's Pride
PPC
$6.64B
| $4.67M | ﹤0.01% |
201,591
+9,736
| +5% | +$236K |
2013 Q2
39 quarters
|
|
2758
Vanguard Russell 1000 Growth ETF
VONG
$48.3B
| $4.67M | ﹤0.01% |
74,192
-63,125
| -46% | -$3.74M |
2015 Q3
30 quarters
|
|
2759
AnaptysBio
ANAB
$1.43B
| $4.65M | ﹤0.01% |
213,741
-343
| -0.2% | -$8.34K |
2017 Q1
24 quarters
|
|
2760
Credit Acceptance
CACC
$5.57B
| $4.64M | ﹤0.01% |
10,653
+5,503
| +107% | +$2.42M |
2013 Q2
39 quarters
|
|
2761
Adaptive Biotechnologies
ADPT
$4.29B
| $4.63M | ﹤0.01% |
523,748
+120,353
| +30% | +$1.06M |
2019 Q2
15 quarters
|
|
|
JPUS
2762
JPMorgan Diversified Return US Equity ETF
JPUS
$457M
| $4.62M | ﹤0.01% |
48,365
+5,289
| +12% | +$510K |
2015 Q4
29 quarters
|
|
2763
CALL
EOG Resources
EOG
$75.7B
| $4.62M | ﹤0.01% |
40,300
-90,700
| -69% | -$11M |
2022 Q2
3 quarters
|
|
2764
Liberty Latin America Class A
LILA
$1.74B
| $4.61M | ﹤0.01% |
817,449
-36,962
| -4% | -$220K |
2015 Q4
29 quarters
|
|
2765
PUT
US Bancorp Series B Preferred Stock
USB.PRH
$731M
| $4.61M | ﹤0.01% |
128,000
-133,900
| -51% | -$2.69M |
2021 Q2
7 quarters
|
|
2766
IBEX
IBEX
$574M
| $4.6M | ﹤0.01% |
188,432
+130,609
| +226% | +$3.49M |
2020 Q3
10 quarters
|
|
|
BWIN
2767
Baldwin Insurance Group
BWIN
$3.08B
| $4.6M | ﹤0.01% |
180,612
+11,801
| +7% | +$328K |
2019 Q4
13 quarters
|
|
2768
CALL
CME Group
CME
$97.2B
| $4.6M | ﹤0.01% |
24,000
+7,300
| +44% | +$1.32M |
2021 Q1
8 quarters
|
|
|
XYZ
2769
PUT
Block Inc
XYZ
$46B
| $4.59M | ﹤0.01% |
66,800
+16,300
| +32% | +$1.22M |
2019 Q1
16 quarters
|
|
2770
iShares Micro-Cap ETF
IWC
$1.34B
| $4.58M | ﹤0.01% |
43,833
-1,061
| -2% | -$119K |
2017 Q1
24 quarters
|
|
2771
CALL
Cintas
CTAS
$78.3B
| $4.58M | ﹤0.01% |
+39,600
| New | +$4.36M |
2023 Q1
0 quarters
|
|
2772
CALL
Travelers Companies
TRV
$75.2B
| $4.58M | ﹤0.01% |
26,700
-9,900
| -27% | -$1.8M |
2022 Q2
3 quarters
|
|
2773
Celestica
CLS
$49B
| $4.58M | ﹤0.01% |
354,771
+9,967
| +3% | +$127K |
2021 Q3
6 quarters
|
|
2774
Golar LNG
GLNG
$5.11B
| $4.57M | ﹤0.01% |
211,675
+117,204
| +124% | +$2.62M |
2013 Q2
39 quarters
|
|
2775
AudioCodes
AUDC
$263M
| $4.57M | ﹤0.01% |
302,895
+61,966
| +26% | +$1.05M |
2018 Q3
18 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.